Antoine Rimbert Selected Research

Triglycerides (Triacylglycerol)

11/2023	MicroRNA-541-3p alters lipoproteins to reduce atherosclerosis by degrading Znf101 and Casz1 transcription factors.
1/2022	The Genetic Spectrum of Familial Hypertriglyceridemia in Oman.
11/2018	Use of plasma metabolomics to analyze phenotype-genotype relationships in young hypercholesterolemic females.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antoine Rimbert Research Topics

Disease

5	Atherosclerosis 03/2024 - 01/2018
5	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2024 - 01/2018
5	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 02/2024 - 01/2016
4	Hypercholesterolemia 03/2024 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 07/2019
3	Fatty Liver 11/2023 - 01/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 01/2020
3	Genetic Risk Score 01/2023 - 01/2018
1	Dyslipidemias (Dyslipidemia) 03/2024
1	Inflammation (Inflammations) 03/2024
1	Food Hypersensitivity (Food Allergy) 03/2024
1	Hepatocellular Carcinoma (Hepatoma) 11/2023
1	Hypoxia (Hypoxemia) 11/2023
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2023
1	Polycythemia (Erythrocytosis) 01/2023
1	Hypertension (High Blood Pressure) 08/2022
1	Rupture 08/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Insulin Resistance 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	COVID-19 01/2021
1	Myocardial Infarction 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 01/2016

Drug/Important Bio-Agent (IBA)

13	LDL CholesterolIBA 02/2024 - 01/2016
10	oxidized low density lipoproteinIBA 02/2024 - 01/2018
7	LipidsIBA 03/2024 - 01/2020
5	Apolipoproteins B (ApoB)IBA 11/2023 - 01/2016
3	LDL Lipoproteins (beta Lipoproteins)IBA 11/2023 - 07/2019
3	Triglycerides (Triacylglycerol)IBA 11/2023 - 11/2018
3	ApolipoproteinsIBA 04/2022 - 01/2016
2	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 03/2024 - 07/2019
2	SubtilisinIBA 03/2024 - 07/2019
2	HDL CholesterolIBA 11/2023 - 01/2022
2	Proprotein Convertase 9IBA 01/2023 - 11/2018
2	CholesterolIBA 01/2022 - 11/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 07/2019
2	LDL Receptors (LDL Receptor)IBA 01/2020 - 11/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2024
1	PCSK9 InhibitorsIBA 03/2024
1	GliadinIBA 03/2024
1	Monoclonal AntibodiesIBA 03/2024
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Lipoproteins (Lipoprotein)IBA 11/2023
1	HDL LipoproteinsIBA 11/2023
1	MicroRNAs (MicroRNA)IBA 11/2023
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2023
1	Lipoprotein(a)IBA 10/2023
1	Proline (L-Proline)FDA Link 01/2023
1	IA 3 (IA-3)IBA 08/2022
1	Nonsense Codon (Nonsense Mutation)IBA 04/2022
1	Alanine Transaminase (SGPT)IBA 01/2021
1	O(4)-methylthymidine triphosphateIBA 01/2016

Therapy/Procedure

1	Bariatric Surgery 01/2022